Human olfactory mucosa in schizophrenia

被引:18
作者
Smutzer, G
Trojanowski, JQ
Lee, VMY
Arnold, SE
机构
[1] Univ Penn, Sch Med, Ctr Neurobiol & Behav, Dept Psychiat, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pathol & Lab Med, Div Anat Pathol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA
关键词
cytoskeleton; dystrophic neurites; olfactory epithelium; schizophrenia;
D O I
10.1177/000348949810700415
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Recent evidence indicates that developmental anomalies may underlie some symptoms of schizophrenia, while psychophysical studies have demonstrated olfactory deficits in this disease. The postmortem olfactory mucosa of elderly schizophrenic patients was examined to characterize the molecular phenotype of this tissue. The distribution of developmentally regulated cytoskeletal proteins, a synaptic vesicle protein, a neural marker protein, a receptor for trophic molecules, axonal guidance and cell migration proteins, and neuronal and glial cytoskeletal proteins of various degrees of phosphorylation was examined by immunohistochemistry. Both schizophrenic and control subjects exhibited dystrophic neurites that were immunoreactive for synaptophysin, microtubule-associated proteins (MAP1B), and neurofilament proteins. No major histochemical or morphologic differences in either the expression or distribution of these proteins were observed in the olfactory epithelium of schizophrenic compared to control subjects. These studies indicated that dystrophic neurites frequently occurred in the olfactory mucosa of both schizophrenics and neurologically normal adults. The absence of major immunocytochemical abnormalities suggested that olfactory deficits in schizophrenia may be due to more subtle cellular or molecular differences or to abnormalities in olfactory regions of the central nervous system rather than in the olfactory epithelium.
引用
收藏
页码:349 / 355
页数:7
相关论文
共 45 条
[1]   ABNORMAL EXPRESSION OF 2 MICROTUBULE-ASSOCIATED PROTEINS (MAP2 AND MAP5) IN SPECIFIC SUBFIELDS OF THE HIPPOCAMPAL-FORMATION IN SCHIZOPHRENIA [J].
ARNOLD, SE ;
LEE, VMY ;
GUR, RE ;
TROJANOWSKI, JQ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10850-10854
[2]  
ARNOLD SE, 1995, AM J PSYCHIAT, V152, P731
[3]  
ARNOLD SE, 1991, ARCH GEN PSYCHIAT, V48, P625
[4]   NEUROBIOLOGICAL INVESTIGATIONS IN CINGULATE CORTEX OF SCHIZOPHRENIC BRAIN [J].
BENES, FM .
SCHIZOPHRENIA BULLETIN, 1993, 19 (03) :537-549
[5]  
BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801
[6]   ALZHEIMERS-DISEASE - ENTER A PROTEASE INHIBITOR [J].
CARRELL, RW .
NATURE, 1988, 331 (6156) :478-479
[7]   PROJECTION DOMAINS OF MAP2 AND TAU DETERMINE SPACINGS BETWEEN MICROTUBULES IN DENDRITES AND AXONS [J].
CHEN, J ;
KANAI, Y ;
COWAN, NJ ;
HIROKAWA, N .
NATURE, 1992, 360 (6405) :674-676
[8]   BETA-AMYLOID PEPTIDE AND AMYLOID PRECURSOR PROTEINS IN OLFACTORY MUCOSA OF PATIENTS WITH ALZHEIMERS-DISEASE, PARKINSONS-DISEASE, AND DOWN-SYNDROME [J].
CRINO, PB ;
MARTIN, JA ;
HILL, WD ;
GREENBERG, B ;
LEE, VMY ;
TROJANOWSKI, JQ .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1995, 104 (08) :655-661
[9]   ISOLATION OF PGP 9.5, A NEW HUMAN NEURON-SPECIFIC PROTEIN DETECTED BY HIGH-RESOLUTION TWO-DIMENSIONAL ELECTROPHORESIS [J].
DORAN, JF ;
JACKSON, P ;
KYNOCH, PAM ;
THOMPSON, RJ .
JOURNAL OF NEUROCHEMISTRY, 1983, 40 (06) :1542-1547
[10]   PRESENCE OF BOTH ODOR IDENTIFICATION AND DETECTION DEFICITS IN ALZHEIMERS-DISEASE [J].
DOTY, RL ;
REYES, PF ;
GREGOR, T .
BRAIN RESEARCH BULLETIN, 1987, 18 (05) :597-600